San Francisco filed a lawsuit this week in San Francisco Superior Court accusing 10 major food manufacturers of knowingly contributing to a public health crisis by producing and marketing ultraprocessed foods, City Attorney David Chiu said. The complaint names Kraft Heinz, Coca-Cola, PepsiCo, Post Holdings, Mondelez International, General Mills, Nestle USA, Kellogg, Mars Incorporated and ConAgra Brands and alleges the companies designed and promoted products to encourage repeat consumption.
The suit seeks restitution and civil penalties to offset the citys health-care costs and asks a court to bar what officials describe as deceptive marketing and to require changes in company practices. The filing frames the dispute as a question of local fiscal responsibility and consumer protection, and it raises issues reporters and policymakers follow closely in our Justice Coverage.
Why the city is suing
San Francisco officials say higher rates of chronic disease impose fiscal and public safety burdens on city services and fall disproportionately on low-income and minority neighborhoods. The complaint argues that ultraprocessed foods have become more prevalent over recent decades and that companies used additives, flavor engineering and marketing tactics to drive repeat purchases and conceal harms.
City Attorney David Chiu said the manufacturers profited while the community absorbed medical and other costs. The complaint seeks monetary relief for those public costs, civil penalties and injunctive remedies aimed at advertising, packaging and product formulation.
What the complaint cites
The lawsuit cites scientific studies and public health data linking high consumption of ultraprocessed foods with a range of health problems, including type 2 diabetes, nonalcoholic fatty liver disease, heart disease and some cancers. It also cites research that associates heavy consumption of these products with mental-health outcomes such as depression, according to local reports.
Research papers commonly use the NOVA classification to define ultraprocessed foods. NOVA, developed by researchers in Brazil, groups foods by the extent and purpose of processing and has been used in epidemiological studies that find correlations between consumption of highly processed products and health risks. The complaint seeks to translate those correlations into liability for manufacturers through causes of action including public nuisance and deceptive business practices under California law.
Legal theory and remedies sought
San Francisco brings claims under state public nuisance law and consumer protection statutes. Public nuisance claims have been used by municipalities in other public-health lawsuits, including litigation over opioids and tobacco. In some prior cases, cities and counties secured multi-billion-dollar settlements from manufacturers and distributors that governments said imposed large public costs.
The city is asking a court to order financial relief to cover medical and other public expenses and to impose injunctive relief that would restrict marketing and require company changes. Those remedies, if granted, could include limits on certain advertising practices, disclosures on packaging, or other compliance measures the court finds appropriate.
Industry response and likely defenses
The companies named in the suit did not immediately respond to the city, the complaint says. A trade group representing many of the manufacturers criticized the legal theory and disputed the use of processing as a proxy for nutritional quality. Sarah Gallo, senior vice president of product policy for the Consumer Brands Association, said classifying foods as unhealthy solely because they are processed can mislead consumers and exacerbate disparities, the group said in a statement.
Legal experts expect the defendants to raise several defenses. Common arguments include that causation is not sufficiently established, that consumers have a role in dietary choices, and that processing alone does not equate to deception or unlawfulness. Courts also scrutinize whether public nuisance law is an appropriate vehicle for disputes over lawful consumer products.
Procedural outlook
Cases of this type typically begin with motions to dismiss, where defendants challenge the legal sufficiency of the complaint and the evidence tying specific company conduct to city harms. If the case survives those motions, it could proceed to discovery, where both sides seek documents and expert testimony, and potentially to trial or negotiated settlement. The litigation timeline is likely to be measured in years.
How courts treat scientific studies and expert testimony will be central. Judges will decide whether the research cited in the complaint can establish the kinds of causal links and proximate cause the law requires to impose liability and financial remedies on manufacturers.
Potential policy spillovers
Beyond the immediate legal stakes, the lawsuit touches on broader policy debates about food labeling, marketing to children, public-health funding and municipal responsibility. If San Francisco obtains significant injunctive relief or monetary awards, other jurisdictions could be encouraged to pursue similar claims or push for statutory changes at the state or federal level to regulate ultraprocessed products.
If the complaint is dismissed, public-health advocates may focus on legislative or regulatory approaches, such as enhanced labeling requirements, targeted taxes, or stricter advertising rules, to address concerns about product formulations and marketing practices.
Analysis
The litigation places accountability and governance at the center of debates over food policy and public spending. San Francisco is advancing a strategy that seeks to hold manufacturers financially responsible for public costs the city links to diet-related disease. That approach mirrors a trend in municipal litigation that shifted public-cost burdens in cases involving tobacco and opioids.
The legal outcome will turn on how courts balance scientific evidence, causation and the boundaries of consumer protection law. Judges will likely scrutinize whether the complaint proves that specific corporate design and marketing practices were a proximate cause of citywide health burdens rather than one factor among many, including personal choices and broader socioeconomic drivers.
For governance and fiscal accountability, the case underscores growing municipal interest in using the courts to seek remedies for population health problems. Whether that strategy succeeds will shape future policymaking, enforcement priorities and the relationship between local governments, industry and public-health regulation.
